by Jameelah Mullen
January 29, 2026
A examine exhibits that the favored treatment might influence your well being and your pockets.
Whereas GLP-1 medicines have revolutionized weight reduction, latest research counsel that their advantages will not be long-lasting for a lot of customers.
Ongoing analysis exhibits that when sufferers cease taking GLP-1 medication, they have an inclination to regain the load. Moreover, the weight-related medical situations that originally prompted the remedy might also return.
In keeping with analysis from the College of Oxford, specialists estimate that many sufferers’ weight will return to pre-treatment ranges inside about 1.7 years after stopping medicines. Cardiometabolic markers, similar to blood stress, ldl cholesterol, and diabetes-related markers, have a tendency to say no roughly 1.4 years after discontinuing the medicines.
Oprah Winfrey has brazenly mentioned her journey with GLP-1. Winfrey stated she gained weight after stopping the remedy and determined to renew the medicines. In an interview with Individuals, she defined that she has dedicated to utilizing GLP-1 for all times.
“In case you have weight problems in your gene pool, I need individuals to comprehend it’s not your fault,” Winfrey informed the outlet. “I need individuals to cease blaming your self for genes and an surroundings you may’t management. I need individuals to have the knowledge, no matter you select to do with it, whether or not you get the medicines, or whether or not you need to preserve weight-reduction plan.”
Nevertheless, long-term use of the drug shouldn’t be accessible to some people. On common, sufferers pay at the very least $4,200 out of pocket annually for GLP-1s like Ozempic, Zepbound, and Wegovy. Sufferers additionally want to think about modifications of their medical insurance. As demand will increase, extra employers have stopped protecting the price of these costly medicines.
In a 2025 examine, researchers analyzed the well being information of 77,310 Danish adults who used Wegovy. The examine discovered that 52 % of individuals stopped taking the drug inside a yr as a consequence of prices. Some respondents famous that they stopped the treatment due to unintended effects, which may embody nausea, vomiting, abdomen ache, and constipation.
Because it turns into clearer that GLP-1s could require a lifelong monetary and medical dedication, researchers and clinicians are more and more contemplating extra everlasting weight-loss choices, similar to Vertical Sleeve Gastrectomy (VSG) and Endoscopic Sleeve Gastroplasty. ESG usually prices round $12,000, and VSG prices about $17,000.
Whereas the preliminary prices are costlier than a yr’s provide of GLP-1, the one-time nature of those procedures would possibly make them a extra enticing choice for sufferers searching for lasting outcomes.
RELATED CONTENT: Elevate Your Excellence: A Birthday Tribute To The Empowerment Architect Of Black Capital, Earl Graves Sr.
